We are committed to finding a cure for WM.

Waldesnstrom’s Macroglobulinemia Foundation of Canada

Abstract: BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia

Go to website – http://pipelinereview.com/index.php/2017012563690/Small-Molecules/BeiGene-Initiates-Global-Phase-III-Trial-of-the-BTK-Inhibitor-BGB-3111-in-Waldenstroms-Macroglobulinemia.html

PDF – BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia | Small Molecules | News Channels

BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s… Continue reading

Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management

http://onlinelibrary.wiley.com/doi/10.1002/ajh.24557/full

Get the PDF Here –

Gertz-2017-Annual Clinical Updates in Hematological Malignancies

Abstract

Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, lymphadenopathy, and rarely hyperviscosity.

Diagnosis: Presence… Continue reading

2016 WMFC Toronto Ed Forum and Fundraiser!

 

2016 WMFC Educational Forum & Fundraiser Toronto

Please join us Friday November 11, 2016 at 7pm – 12am for the 5th WMFC Fundraiser

$125 p/p  **Fundraiser and Educational Forum package deal available

Live Music, Silent Auction, Food Stations… Continue reading